Cardiovascular and circulatory diseases
Participants enrolled in this heart failure trial
Patients in the cardiovascular patient database
Retention rate in cardiovascular study
Meeting or exceeding target enrollment for diverse patient populations
Cardiovascular and circulatory disease trial capabilities
- Monitoring and testing capabilities including blood pressure monitoring, ECG access, Holter and rhythm monitoring access, oxygen saturation monitoring, and related cardiovascular assessments
- Diagnostic and imaging capabilities including ECG, echocardiography access, vascular ultrasound and Doppler study access, and ambulatory blood pressure monitoring
- Multi location patient access across California research sites and referral locations
- Integrated EHR, CTMS, eSource or eCRFs, eReg, and eConsent systems
- Experienced research teams with dedicated operational support and quality oversight
Key differentiators
Reliable start-up execution
Dedicated regulatory and operational support teams streamline activation and help drive predictable study start timelines.
Experienced cardiovascular investigators
Board certified investigators with extensive cardiovascular clinical and research experience across hypertension, atrial fibrillation, coronary artery disease, hyperlipidemia, and heart failure populations.
Real time data management
Integrated platforms (EHR, CTMS, eSource or eCRFs, eReg, eConsent) support continuous documentation workflows and timely data readiness.
Comprehensive recruitment and retention
Demonstrated enrollment and retention performance, including 92% retention in a recent heart failure study (13 enrolled vs 4 target), supported by coordinated site operations and patient engagement practices.
Infrastructure for all study phase
Clinical sites and supporting infrastructure enable cardiovascular trial execution with monitoring, diagnostics, data systems, and operational support aligned to study needs.